SEARCH

SEARCH BY CITATION

References

  • Abraham AM & Walubo A (2005) The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. Int J Antimicrob Agents 25: 392397.
  • Abrahams GL & Hensel M (2006) Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells. Cell Microbiol 8: 728737.
  • Ahmad Z , Sharma S & Khuller GK (2007) Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine 3: 239243.
  • Alvarez-Ordonez A , Begley M , Prieto M , Messens W , Lopez M , Bernardo A & Hill C (2011) Salmonella spp. survival strategies within the host gastrointestinal tract. Microbiology 157: 32683281.
  • Asperilla MO , Smego RA Jr & Scott LK (1990) Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 12: 873889.
  • Bakowski MA , Braun V & Brumell JH (2008) Salmonella-containing vacuoles: directing traffic and nesting to grow. Traffic 9: 20222031.
  • Balland O , Pinto-Alphandary H , Pecquet S , Andremont A & Couvreur P (1994) The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium. J Antimicrob Chemother 33: 509522.
  • Balland O , Pinto-Alphandary H , Viron A , Puvion E , Andremont A & Couvreur P (1996) Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles. J Antimicrob Chemother 37: 105115.
  • Behravesh CB , Jones TF , Vugia DJ et al. (2011) Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996–2005. J Infect Dis 204: 263267.
  • Catron DM , Sylvester MD , Lange Y et al. (2002) The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell Microbiol 4: 315328.
  • Choi S & Lee KD (2008) Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release 131: 7076.
  • Clift MJ , Rothen-Rutishauser B , Brown DM et al. (2008) The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol 232: 418427.
  • Connor BA & Schwartz E (2005) Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 5: 623628.
  • Cordeiro C , Wiseman DJ , Lutwyche P , Uh M , Evans JC , Finlay BB & Webb MS (2000) Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrob Agents Chemother 44: 533539.
  • Crump JA , Luby SP & Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346353.
  • Crump JA , Kretsinger K , Gay K et al. (2008) Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 52: 12781284.
  • de Steenwinkel JE , van Vianen W , Ten Kate MT , Verbrugh HA , van Agtmael MA , Schiffelers RM & Bakker-Woudenberg IA (2007) Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. J Antimicrob Chemother 60: 10641073.
  • Delehanty JB , Bradburne CE , Boeneman K et al. (2010) Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol (Camb) 2: 265277.
  • Dillen K , Vandervoort J , Van den Mooter G & Ludwig A (2006) Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 314: 7282.
  • Ernst RK , Guina T & Miller SI (1999) How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis 179(Suppl 2): S326S330.
  • Feglo PK , Frimpong EH & Essel-Ahun M (2004) Salmonellae carrier status of food vendors in Kumasi, Ghana. East Afr Med J 81: 358361.
  • Fierer J , Hatlen L , Lin JP , Estrella D , Mihalko P & Yau-Young A (1990) Successful treatment using gentamicin liposomes of Salmonella Dublin infections in mice. Antimicrob Agents Chemother 34: 343348.
  • Gamazo C , Lecaroz MC , Prior S , Vitas AI , Campanero MA , Irache JM & Blanco-Prieto MJ (2006) Chemical and biological factors in the control of Brucella and brucellosis. Curr Drug Deliv 3: 359365.
  • Gamazo C , Prior S , Concepcion Lecaroz M et al. (2007) Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections. Expert Opin Drug Deliv 4: 677688.
  • Garcia-del Portillo F , Nunez-Hernandez C , Eisman B & Ramos-Vivas J (2008) Growth control in the Salmonella-containing vacuole. Curr Opin Microbiol 11: 4652.
  • Gelperina S , Kisich K , Iseman MD & Heifets L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172: 14871490.
  • Geoffroy C , Gaillard JL , Alouf JE & Berche P (1987) Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun 55: 16411646.
  • Gunn JS , Gonzalez-Escobedo G & Marshall JM (2011) Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat Rev Microbiol 9: 914.
  • Haraga A , Ohlson MB & Miller SI (2008) Salmonellae interplay with host cells. Nat Rev Microbiol 6: 5366.
  • Hope BK , Baker R , Edel ED et al. (2002) An overview of the Salmonella enteritidis risk assessment for shell eggs and egg products. Risk Anal 22: 203218.
  • Jain N , Rodriguez AC , Kimsawatde G , Seleem MN , Boyle SM & Sriranganathan N (2011) Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308. FEMS Microbiol Lett 316: 16.
  • Kanungo S , Dutta S & Sur D (2008) Epidemiology of typhoid and paratyphoid fever in India. J Infect Dev Ctries 2: 454460.
  • Kim BY , Rutka JT & Chan WC (2010) Nanomedicine. N Engl J Med 363: 24342443.
  • Kullberg M , Owens JL & Mann K (2010) Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes. J Drug Target 18: 313320.
  • Lecaroz C , Gamazo C & Blanco-Prieto MJ (2006) Nanocarriers with gentamicin to treat intracellular pathogens. J Nanosci Nanotechnol 6: 32963302.
  • Lee CM & Tannock IF (2006) Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. Br J Cancer 94: 863869.
  • Lee KD , Oh YK , Portnoy DA & Swanson JA (1996) Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J Biol Chem 271: 72497252.
  • Lutwyche P , Cordeiro C , Wiseman DJ et al. (1998) Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Chemother 42: 25112520.
  • Magallanes M , Dijkstra J & Fierer J (1993) Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother 37: 22932297.
  • Mainardes RM , Gremiao MP , Brunetti IL , da Fonseca LM & Khalil NM (2009) Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J Pharm Sci 98: 257267.
  • Malik-Kale P , Jolly CE , Lathrop S , Winfree S , Luterbach C & Steele-Mortimer O (2011) Salmonella-at home in the host cell. Front Microbiol 2: 125.
  • Mandal M & Lee KD (2002) Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochim Biophys Acta 1563: 717.
  • Miki T , Okada N , Shimada Y & Danbara H (2004) Characterization of Salmonella pathogenicity island 1 type III secretion-dependent hemolytic activity in Salmonella enterica serovar Typhimurium. Microb Pathog 37: 6572.
  • Mingeot-Leclercq MP , Brasseur R & Schanck A (1995) Molecular parameters involved in aminoglycoside nephrotoxicity. J Toxicol Environ Health 44: 263300.
  • Mitev GM , Mellbye BL , Iversen PL & Geller BL (2009) Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer. Antimicrob Agents Chemother 53: 37003704.
  • Monack DM , Bouley DM & Falkow S (2004) Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 199: 231241.
  • Moon C , Kwon YM , Lee WK , Park YJ & Yang VC (2007) In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J Control Release 124: 4350.
  • Mugabe C , Azghani AO & Omri A (2005) Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55: 269271.
  • Murata T , Tseng W , Guina T , Miller SI & Nikaido H (2007) PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol 189: 72137222.
  • Murillo O , Pachon ME , Euba G et al. (2009) Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus. J Antimicrob Chemother 64: 10621066.
  • Ong G , Wilson I , Smyth B & Rooney P (2007) Antimicrobial resistance in non-typhoidal salmonellas from humans in Northern Ireland, 2001–2003: standardization needed for better epidemiological monitoring. Epidemiol Infect 135: 675680.
  • Page-Clisson ME , Pinto-Alphandary H , Chachaty E , Couvreur P & Andremont A (1998a) Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella. Pharm Res 15: 544549.
  • Page-Clisson ME , Pinto-Alphandary H , Ourevitch M , Andremont A & Couvreur P (1998b) Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release 56: 2332.
  • Parry CM , Vinh H , Chinh NT et al. (2011) The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica Serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 5: e1163.
  • Pasmans F , Baert K , Martel A et al. (2008) Induction of the carrier state in pigeons infected with Salmonella enterica subspecies enterica serovar typhimurium PT99 by treatment with florfenicol: a matter of pharmacokinetics. Antimicrob Agents Chemother 52: 954961.
  • Perrett CA & Jepson MA (2007) Applications of cell imaging in Salmonella research. Methods Mol Biol 394: 235273.
  • Piddock LJ (2006) Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4: 629636.
  • Pinto-Alphandary H , Balland O , Laurent M , Andremont A , Puisieux F & Couvreur P (1994) Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium. Pharm Res 11: 3846.
  • Prior S , Gamazo C , Irache JM , Merkle HP & Gander B (2000) Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm 196: 115125.
  • Prost LR , Sanowar S & Miller SI (2007) Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 219: 5565.
  • Quintanar-Guerrero D , Ganem-Quintanar A , Nava-Arzaluz MG & Pinon-Segundo E (2009) Silica xerogels as pharmaceutical drug carriers. Expert Opin Drug Deliv 6: 485498.
  • Rajashekar R , Liebl D , Seitz A & Hensel M (2008) Dynamic remodeling of the endosomal system during formation of Salmonella-induced filaments by intracellular Salmonella enterica. Traffic 9: 21002116.
  • Ranjan A , Pothayee N , Seleem MN , Sriranganathan N , Kasimanickam R , Makris M & Riffle JS (2009a) In vitro trafficking and efficacy of core–shell nanostructures for treating intracellular Salmonella infections. Antimicrob Agents Chemother 53: 39853988.
  • Ranjan A , Pothayee N , Seleem MN et al. (2009b) Antibacterial efficacy of core–shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella model. Int J Nanomedicine 4: 289297.
  • Ranjan A , Pothayee N , Seleem MN , Jain N , Sriranganathan N , Riffle JS & Kasimanickam R (2010a) Drug delivery using novel nanoplexes against a Salmonella mouse infection model. J Nanopart Res 12: 905914.
  • Ranjan A , Pothayee N , Vadala TP et al. (2010b) Efficacy of amphiphilic core–shell nanostructures encapsulating gentamicin in an in vitro Salmonella and Listeria intracellular infection model. Antimicrob Agents Chemother 54: 35243526.
  • Reddy JA & Low PS (2000) Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 64: 2737.
  • Ristuccia AM & Cunha BA (1982) The aminoglycosides. Med Clin North Am 66: 303312.
  • Rosenberger CM , Gallo RL & Finlay BB (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. P Natl Acad Sci USA 101: 24222427.
  • Rudt S & Muller RH (1993) In-vitro phagocytosis assay of nano- and microparticles by chemiluminescense. III. Uptake of differently sized surface surface-modified particles, and its correlation to particle properties and in-vivo distribution. Eur J Pharm Sci 1: 3139.
  • Saito G , Amidon GL & Lee KD (2003) Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther 10: 7283.
  • Sanhai WR , Sakamoto JH , Canady R & Ferrari M (2008) Seven challenges for nanomedicine. Nat Nanotechnol 3: 242244.
  • Seleem MN , Munusamy P , Ranjan A , Alqublan H , Pickrell G & Sriranganathan N (2009a) Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Antimicrob Agents Chemother 53: 42704274.
  • Seleem MN , Jain N , Pothayee N , Ranjan A , Riffle JS & Sriranganathan N (2009b) Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline. FEMS Microbiol Lett 294: 2431.
  • Solnik-Isaac H , Weinberger M , Tabak M , Ben-David A , Shachar D & Yaron S (2007) Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J Clin Microbiol 45: 25752579.
  • Subramanian G , Barry AO , Ghigo E , Raoult D & Mediannikov O (2011) Antibiotic susceptibility and intracellular localization of Diplorickettsia massiliensis. FEMS Immunol Med Microbiol in press.
  • Swenson CE , Stewart KA , Hammett JL , Fitzsimmons WE & Ginsberg RS (1990) Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrob Agents Chemother 34: 235240.
  • Tanaka M , Nakayama H , Haraoka M , Nagafuji T , Saika T & Kobayashi I (1998) Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae. Sex Transm Dis 25: 489493.
  • Vakulenko SB & Mobashery S (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16: 430450.
  • Vazquez-Boland JA , Kuhn M , Berche P et al. (2001) Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14: 584640.
  • Vitas AI , Diaz R & Gamazo C (1996) Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with brucella abortus. Antimicrob Agents Chemother 40: 146151.
  • Voetsch AC , Van Gilder TJ , Angulo FJ et al. (2004) FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 38: S127S134.
  • Wasaznik A , Grinholc M & Bielawski KP (2009) [Active efflux as the multidrug resistance mechanism]. Postepy Hig Med Dosw (Online) 63: 123133.
  • Wasungu L & Hoekstra D (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116: 255264.
  • Webb MS , Boman NL , Wiseman DJ et al. (1998) Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother 42: 4552.
  • Xue JM , Tan CH & Lukito D (2006) Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. J Biomed Mater Res B Appl Biomater 78: 417422.
  • Zahr AS , Davis CA & Pishko MV (2006) Macrophage uptake of core–shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22: 81788185.
  • Zuhorn IS , Bakowsky U , Polushkin E , Visser WH , Stuart MC , Engberts JB & Hoekstra D (2005) Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol Ther 11: 801810.